Exagen Inc (XGN) is around the top of the Diagnostics & Research industry according to InvestorsObserver. XGN received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. Exagen Inc also achieved a score of 76 in the Diagnostics & Research industry, putting it above 76 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 103 out of the 148 industries.
XGN has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on XGN!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Exagen Inc Stock Today?
Exagen Inc (XGN) stock is trading at $2.53 as of 10:02 AM on Monday, Jul 31, a gain of $0.12, or 4.77% from the previous closing price of $2.41. The stock has traded between $2.44 and $2.59 so far today. Volume today is low. So far 12,133 shares have traded compared to average volume of 18,456 shares.
Click Here to get the full Stock Report for Exagen Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
